WAAW 2021 Events

This session is part of a weeklong, Africa-wide series of jointly-organised WAAW activities exploring the theme ‘AMR Governance: Preventing AMR is Our Shared Responsibility’ .

This event will feature the release of the executive summary of the first joint EARS-Net/CAESAR report on AMR in clinical isolates across the whole region. Following remarks from leaders from ECDC and WHO, a scientific panel will discuss the results from AMR and antibiotic usage surveillance in both human and veterinary/agricultural sector.

This event will introduce the WHO EML Antibiotic Book - what it is, how it was developed and how it can be used, and what does WHO expect from the public consultation phase?

Read more

In this GARDP webinar, panelists will discuss the roles industry, the public sector and not-for-profits can play in developing and ensuring access to new antibiotics and how the three alone and together can work to achieve this goal.

Maternal infections and sepsis are among the leading causes of mortality and morbidity, accounting for at least 11% of all maternal deaths. Most maternal infections and their consequences can be avoided by implementing appropriate IPC practices, antenatal screening and appropriate antibiotic use. This webinar will bring together global experts to discuss the maternity care and IPC intersection. WHO will also launch two new modules of the IPC training package for a safe care pathway for women and newborns.

This session is part of a weeklong, Africa-wide series of jointly-organised WAAW activities exploring the theme ‘AMR Governance: Preventing AMR is Our Shared Responsibility’.

This youth-led summit aims to empower healthcare students all around the world while taking into consideration regional perspectives and different regional needs for AMR. The multi-day event is organized by the World Health Students Alliance (WHSA) including IADS, IFMSA, IPSF and IVSA as well as IAAS (representing dentistry, medical, pharmaceutical, veterinary, and agriculture students worldwide respectively).

This session, hosted by the Africa CDC, will be moderated by patient advocate Vanessa Carter, and is part of a weeklong, Africa-wide series of jointly-organised WAAW activities exploring the theme ‘AMR Governance: Preventing AMR is Our Shared Responsibility’.

Follow : #AfricaWAAW

This session, organised by WHO AFRO, is part of a weeklong, Africa-wide series of jointly-organised WAAW activities exploring the theme ‘AMR Governance: Preventing AMR is Our Shared Responsibility’.

This session will discuss the rational use of antibiotics for the treatment of COVID-19 patients and the current and future risk of increasing AMR due to COVID-19 pandemic.

Resistance to antifungals is a mounting global public health threat. Existing antifungal drugs are often associated with important negative side effects. Few new drugs are under development. Fungal infections also frequently complicate other illnesses. This was most recently illustrated by the devastating impact of mucormycosis and invasive aspergillosis during the COVID-19 pandemic. This event will introduce WHO’s response to this problem including an initiative to develop a global priority fungal pathogens list of public health importance.

View the recording in two parts:

Unless the world takes collective action across human, animal, plant and environmental health sectors, common infections will become untreatable as resistance to antimicrobials grows. Urgent action is needed. Civil society plays an important role in galvanising such action by various stakeholders including governments, donors, academia and the general public. This webinar will discuss and highlight the current and potential response of civil society organizations (CSOs) to AMR.

Following World Children’s Day (20 November) join this Pediatric Infectious Diseases Society (PIDS) webinar, which will discuss the threat of antimicrobial resistance for children’s health.

This session will provide a technical brief on Rational use of antibiotics and antimicrobial resistance, followed by testimonials from drug-resistant TB survivors. Webinar participants will then share strategies for the way forward.

This session, organised by Africa CDC and UNEP, is part of a weeklong, Africa-wide series of jointly-organised WAAW activities exploring the theme ‘AMR Governance: Preventing AMR is Our Shared Responsibility’.

This session will explore how selected innovations, including as related diagnostics and AMR stewardship, can support the appropriate use of antimicrobial medicines, and how these can help achieve relevant United Nations (UN) Sustainable Development Goals (SDGs) and associated targets.

This session, organised by OIE, is part of a weeklong, Africa-wide series of jointly-organised WAAW activities exploring the theme ‘AMR Governance: Preventing AMR is Our Shared Responsibility’.

Learn about the Tailoring Antimicrobial Resistance Programmes (TAP) Quick Guide and Toolbox recently developed by the WHO Regional Office for Europe. These tools aim to strengthen efforts to tackle antimicrobial resistance through a behavioural insights approach. The TAP Quick Guide follows a step-by-step, practical approach to design and implement a targeted behaviour change intervention to address drivers of AMR in human and animal health.

The HIV Drug Resistance Report 2021 will be launched during this webinar, organized as part of the World Antimicrobial Awareness Week 2021. The webinar aims to spread awareness of the burden of HIV drug resistance and to advocate to stop HIV drug resistance through implementation of a comprehensive prevention and response approach involving all stakeholders as outlined in the WHO global action plan to prevent, monitor and respond to HIV drug resistance.

Learn about the Tailoring Antimicrobial Resistance Programmes (TAP) Quick Guide and Toolbox recently developed by the WHO Regional Office for Europe. These tools aim to strengthen efforts to tackle antimicrobial resistance through a behavioural insights approach. The TAP Quick Guide follows a step-by-step, practical approach to design and implement a targeted behaviour change intervention to address drivers of AMR in human and animal health.